Lindsey J Wanberg, Rebecca E Rottapel, Michelle L Reid, Suzanne M Bertisch, Morgan Bron, Vishesh K Kapur, Shay Bujanover, Zinta Harrington, Jessie P Bakker, Sogol Javaheri, Mark Hanson, Kathleen Figetakis, Kathy Page, Sherry Hanes, Kathleen F Villa, Susan Redline
STUDY OBJECTIVES: Excessive daytime sleepiness (EDS) is a treatment target for many patients with obstructive sleep apnea (OSA). We aimed to understand the prevalence, risk factors, and quality of life associated with EDS in a nonclinical, "real world" sample of patients with OSA. METHODS: Cross-sectional survey of patients with OSA participating in an online peer support community, assessing demographics, comorbidities, treatment, and quality of life. Differences in those with and without EDS (Epworth Sleepiness Scale > and ≤ 10) were assessed...
December 1, 2021: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine